Ann Brady

Ann Brady, PhD., currently serves as President, Theravance Biopharma Ireland and a board member of An2H Discovery Ltd. Ann brings over 20 years experience in the bio-pharma industry through global roles in business development, alliance management, corporate strategy and commercial operations gained in both developed and emerging markets. Ann served in senior executive roles at Shire, plc and élan Corporation, plc. She holds a BA (Mod) Natural Sciences and a PhD (Chemistry) from Trinity College, Dublin and is a member of the Institute of Directors of Ireland (MIoD).